Brii Bio acquires Vir’s antibody rights for Hepatitis B in Greater China
The development adds further growth to Brii Bio’s clinical pipeline of therapeutic candidates for HBV.
Asia-Pacific
Latest in
Asia-Pacific
HDT Bio receives Emergency Use Approval for Covid-19 vaccine in India
Gemcovac became the first saRNA vaccine to obtain approval for use in humans in India.
Japan’s MHLW accepts GSK’s submission for shingles vaccine in adults
The filing is based on data from six clinical trials in subjects of the age 18 years and above.
invoX Pharma agrees to acquire biopharma firm F-star Therapeutics for $161m
Four programmes of F-star are currently in the clinic while various other undisclosed programmes are in the developmental stage.
Novavax’s Covid-19 vaccine gets Taiwan FDA EUA for use in adults
The vaccine doses for Taiwan would be the first shipment to a nation participating in the COVAX Facility.
BioMarin’s Voxzogo obtains Japan’s MHLW approval for achondroplasia
In a Phase III trial, treatment with Voxzogo offered transient declines in blood pressure.
Australia grants provisional registration for Novavax’s Covid-19 booster
The latest provisional registration is based on findings from two Phase II trials and the COV-BOOST trial of the vaccine.
China NMPA grants approval for BeiGene’s nasopharyngeal cancer therapy
The approval is based on clinical data from the Phase III RATIONALE 309 clinical trial of tislelizumab plus chemotherapy.